| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/12/1996 | WO1996027392A1 Antigen presenting system and methods for activation of t-cells |
| 09/12/1996 | WO1996027386A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 09/12/1996 | WO1996027378A2 Use of penciclovir for the treatment of human herpes-virus-8 |
| 09/12/1996 | CA2214776A1 Antitumour isocoumarins |
| 09/11/1996 | EP0731109A1 Purification of D-factor |
| 09/11/1996 | EP0731101A1 3-Benzyl-benzothiophenes |
| 09/11/1996 | EP0731099A1 N-(3-benzofuranyl)urea-derivatives |
| 09/11/1996 | EP0731098A1 Alpha-substituted-3-benzyl-benzofurans |
| 09/11/1996 | EP0731097A1 Novel benzofuran pharmaceutical compounds |
| 09/11/1996 | EP0731093A1 Naphthyl pharmaceutical compounds |
| 09/11/1996 | EP0731078A1 Terpene-quinone with antitumor activity |
| 09/11/1996 | EP0730871A1 Radioactive chitosan complex and the use thereof for radiation therapy |
| 09/11/1996 | EP0730870A1 Radioactive chitosan complex and its macroaggregates for use in internal radiation therapy and their preparation method |
| 09/11/1996 | EP0730660A1 Chimeric proteins including protease nexin-1 variants |
| 09/11/1996 | EP0730648A1 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER |
| 09/11/1996 | EP0730607A1 Novel integrin-binding peptides |
| 09/11/1996 | EP0730606A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR |
| 09/11/1996 | EP0730605A1 Substituted di- and tripeptide inhibitors of protein:farnesyl transferase |
| 09/11/1996 | EP0730598A1 Hindered esters of rapamycin and their use as pharmaceuticals |
| 09/11/1996 | EP0730597A1 Heterocyclic esters of rapamycin and pharmaceutical compositions containing them |
| 09/11/1996 | EP0730590A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 09/11/1996 | EP0730474A1 Estramustine formulations with improved pharmaceutical properties |
| 09/11/1996 | EP0730470A1 Improved interferon polymer conjugates |
| 09/11/1996 | EP0730467A1 Inhibitors of farnesyl-protein transferase |
| 09/11/1996 | EP0730447A1 Fatty acid delivery system |
| 09/11/1996 | EP0730446A1 Protein kinase c activators and their use in decreasing expression of cell antigens |
| 09/11/1996 | EP0614366B1 Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours |
| 09/11/1996 | EP0534944B1 Antibodies specific for elam-1 and the use thereof |
| 09/11/1996 | CN1130944A Diagnostic prognostic and therapeutic method for solid non-lymphoid tumors and their metastases |
| 09/11/1996 | CN1130909A 5-(1-fluoro-vinyl)-1H-pyrimidine-2,4-dione derivatives useful as antineoplastic agents |
| 09/11/1996 | CN1130903A Condensed 1,2-indene dihydride and its salt for medicine |
| 09/11/1996 | CN1130899A Novel structural analogues of vitamin D |
| 09/11/1996 | CN1130866A Anti-angiogenic compositions and method of use |
| 09/11/1996 | CN1130626A Adhesion receptor antagonists |
| 09/11/1996 | CN1130532A Modulation of cellular activity |
| 09/11/1996 | CN1032750C Process for prepn. of ureido derivatives of poly 4-amino-2-carboxy-1-methyl compounds |
| 09/11/1996 | CA2171404A1 3-benzyl-benzothiophenes |
| 09/11/1996 | CA2171399A1 Substituted-3-benzyl-benzofurans |
| 09/10/1996 | US5554755 Acylation |
| 09/10/1996 | US5554724 Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof |
| 09/10/1996 | US5554645 Antineoplastic cocoa extracts and methods for making and using the same |
| 09/10/1996 | US5554642 Arylalkyl(thio) amides |
| 09/10/1996 | US5554638 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders |
| 09/10/1996 | US5554637 Use of leflunomide for inhibiting interleukin 1 alpha |
| 09/10/1996 | US5554628 Method for minimizing the uterothrophic effect of tamoxifen and tamoxifen analogs |
| 09/10/1996 | US5554622 Asymmetrically substituted bisnaphthalimides |
| 09/10/1996 | US5554612 Immunosuppressants, viricides, antitumor and antiinflammatory agents |
| 09/10/1996 | US5554602 Labelling of hormones with rhenium and tecnetium |
| 09/10/1996 | US5554599 22-thio vitamin D derivatives |
| 09/10/1996 | US5554594 Imidazolidine derivatives |
| 09/10/1996 | US5554512 Isolated dna sequence encoding flt3 ligand polypeptide; expression vector comprising the sequence; host cell transformed or transfected with the vector; culture process for producing flt3-l polypeptide; nucleic acid sequences |
| 09/10/1996 | US5554506 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 09/10/1996 | CA2036507C 2'-deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions |
| 09/07/1996 | CA2170824A1 N-(3-benzofuranyl)urea-derivatives |
| 09/06/1996 | WO1996027008A2 Agent for treating tumours and other hyperplasia |
| 09/06/1996 | WO1996027007A1 A novel growth factor and a genetic sequence encoding same |
| 09/06/1996 | WO1996027006A2 Human vegf-specific antisense oligonucleotides |
| 09/06/1996 | WO1996026964A1 Bispecific antibody effective to treat b-cell lymphoma and cell line |
| 09/06/1996 | WO1996026961A2 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
| 09/06/1996 | WO1996026932A1 2-arylbenzazole compounds |
| 09/06/1996 | WO1996026743A1 Radiation enhanced gene therapy for treatment of tumors |
| 09/06/1996 | WO1996026738A1 Pharmaceutical compositions for controlled release of soluble receptors |
| 09/06/1996 | WO1996026736A1 Vascular endothelial growth factor-b |
| 09/06/1996 | WO1996026735A1 Method for stimulating an immune response |
| 09/06/1996 | WO1996026733A1 Codominance-mediated toxins |
| 09/06/1996 | WO1996026730A1 Use of acid-sensitive organo- transition metal compounds in cancer treatment |
| 09/06/1996 | WO1996026727A1 Methods of inhibiting ovarian cancer |
| 09/06/1996 | WO1996026723A1 Benzothiopyranoindazoles antitumor agents |
| 09/06/1996 | WO1996020277A3 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen |
| 09/06/1996 | WO1996020219A3 Murine monoclonal anti-idiotype antibody 3h1 |
| 09/06/1996 | WO1996019965A3 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
| 09/06/1996 | CA2247207A1 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
| 09/06/1996 | CA2214080A1 Methods of inhibiting ovarian cancer |
| 09/06/1996 | CA2213344A1 Use of acid-sensitive organo-transition metal compounds in cancer treatment |
| 09/06/1996 | CA2211706A1 Benzothiopyranoindazoles antitumor agents |
| 09/04/1996 | EP0729964A1 Phosphorous-containing benzothiophenes |
| 09/04/1996 | EP0729951A1 Naphthyl compounds, intermediates, compositions, and methods |
| 09/04/1996 | EP0729755A2 2-Phenyl-3-aroylbenziothiophenen for inhibiting ovarian cancer |
| 09/04/1996 | EP0729754A2 2-Phenyl-3-aroylbonzothiophenes for inhibiting estrogen positive tumors of the brain or CNS |
| 09/04/1996 | EP0729516A1 Recombinant adenoviruses for gene therapy in cancers |
| 09/04/1996 | EP0729515A1 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting |
| 09/04/1996 | EP0729507A1 Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor |
| 09/04/1996 | EP0729473A1 Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use |
| 09/04/1996 | EP0729460A1 Substituted 5-ring heterocycles, their preparation and their use |
| 09/04/1996 | EP0729354A1 Farnesyl derivatives and pharmaceutical compositions containing them |
| 09/04/1996 | EP0729300A1 Novel fas protein and methods of use thereof |
| 09/04/1996 | EP0644181B1 Amino acid derivative and use thereof |
| 09/04/1996 | EP0560932B1 Methods and compositions for the suppression of neu mediated transformation |
| 09/04/1996 | EP0458878B1 Monoclonal antibody to novel antigen associated with human tumors |
| 09/04/1996 | EP0355131B1 Acyl deoxyribonucleoside derivatives and uses thereof |
| 09/04/1996 | CN1130193A Monoclonal antibody of human combining mosaic for recognizing epidermal growth factor receptor (EGF-R) and its diagnosis and therapeutical use |
| 09/04/1996 | CN1130184A New Tricyclic amide compounds, processes for their preparation and the pharmaceutical compositions which contain them |
| 09/03/1996 | US5552545 5-deaza-10-oxo-and 5-deaza-10-thio-5,6,7,8-tetrahydrofolic acids |
| 09/03/1996 | US5552544 Antitumor agents |
| 09/03/1996 | US5552536 DNA encoding precursor of interleukin-1 beta converting enzyme - related cysteine proteinase III (ice rel-III) |
| 09/03/1996 | US5552520 Such as somatostatin analogs or bombesin analogs |
| 09/03/1996 | US5552412 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis |
| 09/03/1996 | US5552400 Inhibitors of protease activity |
| 09/03/1996 | US5552396 Bis-indolemaleimide macrocyclic derivatives, |
| 09/03/1996 | US5552311 Purine nucleoside phosphorylase gene therapy for human malignancy |